technetium tc 99m etidronate has been researched along with hydroxyproline in 2 studies
| Studies (technetium tc 99m etidronate) | Trials (technetium tc 99m etidronate) | Recent Studies (post-2010) (technetium tc 99m etidronate) | Studies (hydroxyproline) | Trials (hydroxyproline) | Recent Studies (post-2010) (hydroxyproline) |
|---|---|---|---|---|---|
| 96 | 3 | 2 | 10,942 | 334 | 1,426 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexandre, C; Chapuy, MC; Charhon, S; Delmas, P; Mathieu, L; Meunier, PJ; Salson, C | 1 |
| Boyce, BF; Boyle, IT; Fogelman, I; Ralston, S; Smith, ML | 1 |
2 other study(ies) available for technetium tc 99m etidronate and hydroxyproline
| Article | Year |
|---|---|
Skeletal distribution and biochemical parameters of Paget's disease.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Antibodies; Bone and Bones; Etidronic Acid; Female; Humans; Hydroxyproline; Hypocalcemia; Male; Middle Aged; Organotechnetium Compounds; Osteitis Deformans; Parathyroid Hormone; Radiography; Radionuclide Imaging; Technetium | 1987 |
Correlation of skeletal uptake of 99mTc-diphosphonate and alkaline phosphatase before and after oral diphosphonate therapy in Paget's disease.
Topics: Administration, Oral; Aged; Alkaline Phosphatase; Bone and Bones; Drug Interactions; Etidronic Acid; Humans; Hydroxyproline; Middle Aged; Organotechnetium Compounds; Osteitis Deformans; Radionuclide Imaging; Technetium | 1984 |